XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From (Used In) Operating Activities      
Net Loss $ (50,149,077) $ (40,763,573) $ (40,377,160)
Non-Cash Adjustments      
Depreciation and Amortization 4,931,692 2,587,901 2,309,571
Stock-Based Compensation 12,711,084 15,775,553 17,302,833
Impairment of Patents and Trademarks 41,869 97,675 80,163
Loss on Fixed Asset Disposal 0 35,350 183,614
Reserve on Trade Accounts Receivable 1,574,000    
Change in Inventory Reserve for Obsolescence 4,358,062 290,405 519,950
Loss on Goodwill and Other Intangible Asset Impairment 2,136,993    
(Increase) Decrease in Operating Assets      
Accounts Receivable (1,842,715) (1,316,542) (853,547)
Accrued Revenues in Excess of Billings 103,358 (269,129)  
Utility Improvement Refund/Employee Retention Credit Receivable 258,434 (466,705)  
Inventories (2,090,523) 593,608 (6,571,108)
Manufacturing Vendor Prepayments 594,870 (494,620) (19,019)
Prepaid Expenses and Other Assets 167,837 (95,244) (526,825)
Increase (Decrease) in Operating Liabilities      
Accounts Payable 358,883 (843,015) 537,607
Accrued Expenses 745,904 251,231 436,276
Unearned Revenue (10,225) 1,268 (13,355)
Income and Other Taxes Payable (168,270) 94,755 10,589
Net Cash Flows Used in Operating Activities (26,277,824) (24,521,082) (26,980,411)
Cash Flows Used In Investing Activities      
Purchases of Fixed Assets (5,323,483) (1,723,622) (3,809,268)
Investments in Patents and Trademarks (632,483) (499,031) (593,184)
Investments in Licenses, Intangibles and Other Assets (10,500,000) (16,523,163) (200,000)
Business Acquisition, net of cash acquired   (2,300,000)  
Investments in Software Development (125,000) (125,000) (250,000)
Investment in Atomistic (2,500,000)    
Investments in Other Assets (200,000)    
Net Cash Flows Used in Investing Activities (19,280,966) (21,170,816) (4,852,452)
Cash Flows Provided by (Used In) Financing Activities      
Proceeds from Exercise of Warrants     34,715,728
Proceeds from Exercise of Stock Options 21,196 57,712 782,277
Proceeds from Common Stock Offering, Net     91,613,587
Purchases of Treasury Stock (470,757) (2,005,744)  
Preferred Dividend Settlement Payment     (10,000,000)
Employee Tax Withholdings Payment     (1,144,364)
Net Cash Flows Provided by (Used in) Financing Activities (449,561) (1,948,032) 115,967,228
Net Increase (Decrease) in Cash and Cash Equivalents (46,008,351) (47,639,930) 84,134,365
Cash and Cash Equivalents - Beginning of Period 72,563,943 120,203,873 36,069,508
Cash and Cash Equivalents - End of Period 26,555,592 72,563,943 120,203,873
Supplemental Disclosures      
Non-Cash Investment in Licenses 1,000,000 11,500,000 1,294,262
Investment in Atomistic - Equity issued 3,284,126    
Stock-Based Compensation Expense - Expensed less Previously Issued $ 92,454 $ 61,824 $ (1,127,091)